Functional CT imaging techniques for the assessment of angiogenesis in lung cancer

Translational Lung Cancer Research

Volumn 1, Issue 1, 2012, Pages 78-83

  Henzler, Thomas ^a   Shi, Jingyun ^b   Jafarov, Hashim ^a   Schoenberg, Stefan O ^a   Manegold, Christian ^a   Fink, Christian ^a   Schmid Bindert, Gerald ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883797411     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2012.01.02     Document Type: Article

References (30)

1. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
2. Swensen SJ. Functional CT: lung nodule evaluation. Radiographics 2000;20:1178-81.
3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.
4. Herbst RS, Johnson DH, Mininberg E, et al. Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005;23:2544-55.
5. Viamonte M Jr. Angiographic evaluation of lung neoplasms. Radiol Clin North Am 1965;3:529-42.
6. Littleton JT, Durizch ML, Moeller G, et al. Pulmonary masses: contrast enhancement. Radiology 1990;177:861-71.
7. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80.
8. Kono M, Adachi S, Kusumoto M, et al. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging 1993;8:18-26.
9. Gückel C, Schnabel K, Deimling M, et al. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996;200:681-6.
10. de Langen AJ, van den Boogaart V, Lubberink M, et al. Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med 2011;52:48-55.
11. Lind JS, Postmus PE, Smit EF. Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report. J Thorac Oncol 2010;5:554-7.
12. Li Y, Yang ZG, Chen TW, et al. Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64-detector row CT. Clin Radiol 2008;63:629-35.
13. Swensen SJ, Brown LR, Colby TV, et al. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194:393-8.
14. Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material-a preliminary report. Radiology 1992;182:343-7.
15. Yamashita K, Matsunobe S, Tsuda T, et al. Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology 1995;194:399-405.
16. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997;205:471-8.
17. Tateishi U, Kusumoto M, Nishihara H, et al. Contrastenhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer 2002;95:835-42.
18. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-9.
19. Ng QS, Goh V, Milner J, et al. Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007;67:417-24.
20. Lind JS, Meijerink MR, Dingemans AM, et al. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? Eur Radiol 2010;20:2890-8.
21. Ng QS, Goh V, Milner J, et al. Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer. Lung Cancer 2010;69:71-6.
22. Sauter AW, Merkle A, Schulze M, et al. Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions. Eur J Radiol 2012;81:2853-9.
23. Ohno Y, Koyama H, Matsumoto K, et al. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology 2011;258:599-609.
24. Johnson TR, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience. Eur Radiol 2007;17:1510-7.
25. Altenbernd J, Heusner TA, Ringelstein A, et al. Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol 2011;21:738-43.
26. Graser A, Becker CR, Staehler M, et al. Single-phase dualenergy CT allows for characterization of renal masses as benign or malignant. Invest Radiol 2010;45:399-405.
27. Apfaltrer P, Meyer M, Meier C, et al. Contrast-Enhanced Dual-Energy CT of Gastrointestinal Stromal Tumors: Is Iodine-Related Attenuation a Potential Indicator of Tumor Response? Invest Radiol 2012;47:65-70.
28. Chae EJ, Song JW, Seo JB, et al. Clinical utility of dualenergy CT in the evaluation of solitary pulmonary nodules: initial experience. Radiology 2008;249:671-81.
29. Swensen SJ, Morin RL, Aughenbaugh GL, et al. CT reconstruction algorithm selection in the evaluation of solitary pulmonary nodules. J Comput Assist Tomogr 1995;19:932-5.
30. Schmid-Bindert G, Henzler T, Chu TQ, et al. Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? Eur Radiol 2012;22:93-103.